Form 4: IN8BIO Director Travis Whitfill Acquires Stock Options
SEC Form 4 Filing
Director Travis Whitfill acquired stock options in IN8BIO, INC. on June 12, 2024.
Summary
- On June 12, 2024, Travis Whitfill, a director of IN8BIO, INC. (INAB), acquired stock options.
- The stock options grant the right to buy 33,650 shares of common stock at an exercise price of $1.47.
- The options vest in equal monthly installments starting July 12, 2024, with full vesting by the date of the company's next annual meeting of stockholders, contingent on continued service.
- Following the transaction, Whitfill directly owns 33,650 derivative securities.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a stock option grant. It doesn't inherently convey positive or negative sentiment.
Future Outlook
The options vest monthly starting July 12, 2024, and will be fully vested by the next annual meeting, subject to continued service.
Industry Context
This is a standard disclosure related to insider transactions, common in publicly traded companies. It provides transparency regarding the holdings and transactions of company insiders.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment as it aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/12/2024 | Date of the stock option transaction |
| 07/12/2024 | Vesting of the stock options begins in monthly installments |
| 06/12/2034 | Expiration date of the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.